Ekso Bionics (EKSO)
(Delayed Data from NSDQ)
$1.16 USD
-0.01 (-0.43%)
Updated Sep 10, 2024 10:29 AM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
EKSO 1.16 -0.01(-0.43%)
Will EKSO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EKSO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EKSO
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates
EKSO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
All You Need to Know About Ekso Bionics (EKSO) Rating Upgrade to Buy
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Other News for EKSO
Ekso Bionics prices $6M public offering at $1.00 per share
Ekso Bionics prices $6M offering
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering
Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session